The SIRT1 inhibitor EX-527, when delivered via hypoxia-sensitive liposomes, increases H3K9 acetylation at the p21 promoter by 3.5-fold and enhances radiation-induced cell death in hypoxic GBM xenografts by 50% (Li et al., 2023). This evidence concerns the gene CDKN1A and glioblastoma.